Olfactory impairment in presymptomatic Alzheimer's disease. - sprookjes - yvandenbroek - TriplyDB

Olfactory impairment in presymptomatic Alzheimer's disease.

Olfactory impairment in presymptomatic Alzheimer's disease.

http://www.wikidata.org/entity/Q33802937

about

Olfactory dysfunction predicts 5-year mortality in older adults Olfactory dysfunction in Alzheimer's disease Is neurodegenerative disease a long-latency response to early-life genotoxin exposure?At the interface of sensory and motor dysfunctions and Alzheimer's disease.Smell and taste disorders.Individuals at risk for Alzheimer's disease show differential patterns of ERP brain activation during odor identification Functional connectivity during recognition memory in individuals genetically at risk for Alzheimer's disease Dysfunctional Incidental Olfaction in Mild Cognitive Impairment (MCI): An Electroencephalography (EEG) Study Computational genetics analysis of grey matter density in Alzheimer's disease.Olfactory dysfunction, central cholinergic integrity and cognitive impairment in Parkinson's disease Determination of odor detection threshold in the Gottingen minipig.The PRIPS study: screening battery for subjects at risk for Parkinson's disease.The 32-year relationship between cholesterol and dementia from midlife to late life Odor identification and mortality in old age.Lewy bodies and olfactory dysfunction in old age Loss of motor function in preclinical Alzheimer's disease Comparison of the efficacy of aroma-acupressure and aromatherapy for the treatment of dementia-associated agitation.Odor identification and Alzheimer disease biomarkers in clinically normal elderly.Harm avoidance and risk of Alzheimer's disease.Does the cycad genotoxin MAM implicated in Guam ALS-PDC induce disease-relevant changes in mouse brain that includes olfaction?Poorer Financial and Health Literacy Among Community-Dwelling Older Adults With Mild Cognitive Impairment.Olfactory discrimination predicts cognitive decline among community-dwelling older adults.Somatostatinergic systems: an update on brain functions in normal and pathological aging.Pathological α-synuclein distribution in subjects with coincident Alzheimer's and Lewy body pathology.Factors predicting reversion from mild cognitive impairment to normal cognitive functioning: a population-based study Olfactory assessment using the NIH Toolbox Olfaction and apathy in Alzheimer's disease, mild cognitive impairment, and healthy older adults.Genome-wide Meta-analysis on the Sense of Smell Among US Older Adults.Research on the premotor symptoms of Parkinson's disease: clinical and etiological implications.Fus1 KO Mouse As a Model of Oxidative Stress-Mediated Sporadic Alzheimer's Disease: Circadian Disruption and Long-Term Spatial and Olfactory Memory Impairments The acceptability of TV-based game platforms as an instrument to support the cognitive evaluation of senior adults at home.Odor Identification Screening Improves Diagnostic Classification in Incipient Alzheimer's Disease.Olfactory dysfunction: common in later life and early warning of neurodegenerative disease.Olfactory system and demyelination.The role of olfactory challenge tests in incipient dementia and clinical trial design.Increased dopaminergic cells and protein aggregates in the olfactory bulb of patients with neurodegenerative disorders.Odor identification in frontotemporal lobar degeneration subtypes.The human brain representation of odor identification.Olfaction deterioration in cognitive disorders in the elderly.The Prevalence of Anosmia and Associated Factors Among U.S. Black and White Older Adults.

P2860

Q21131947-E453A85B-BEBF-4374-B2BC-74D9F7C10723 Q26752969-65F3C306-4EBE-48FC-BB71-5CF2AD959EF9 Q26824755-3BE8D2AA-4A91-4961-97E3-98F52F35DA2A Q27000410-D02FA8ED-87E5-42B6-9335-993E91691F9D Q28265975-34478563-E3A4-4EBD-834F-B91A7B48B5B1 Q28392914-BE7BB9CB-27AC-4B8E-AA1E-383FB80C5675 Q28394145-0F4391F9-1898-49E7-9AF6-E5894AE53AAD Q30436413-C77D48EA-45B0-491B-A448-C2FDC8C1EC89 Q30487243-101D69CB-D291-4768-A815-271824A80EA5 Q33882719-654DC491-D9D5-4B55-91D1-327369EE364A Q34145250-4C35512F-792E-4DF0-967F-0616E8F71751 Q34361343-7CE51E89-A5A0-443D-9611-F4E259006870 Q34370050-3BF2C7B1-8FE4-4DFF-BDA3-9E2E4189B5EA Q34408546-3F145FCC-9260-497B-A330-046C30730363 Q34776843-4749EFF8-8B9C-4ABF-B69A-489F2D3B40BA Q35064701-0F143A69-6205-4F55-9545-2B275D32B00B Q35238048-0BE8F23A-E80D-4AF6-9B1F-E0CFCB5392D7 Q35671009-BCAA1001-E7A8-4390-821A-B62BA0497593 Q35832942-D9B51077-044F-4CC0-9282-B0F72B4AB137 Q35836177-F29966F3-7A99-46DD-8D1F-EFBA9DB26612 Q35904507-FAE2E44B-F6CA-4AF5-B76E-1BA5B9EC769B Q36001600-F7467B5F-04B1-4175-B3EE-7B9757AD708F Q36449496-4D06478E-01E5-4687-8C4A-343A6D28EBBB Q36581696-8F9648DC-698B-4A05-BD2C-729D1B0EB886 Q36721497-D088D914-23C9-4257-9977-991F0016A924 Q36870203-481093E2-DB7D-4EC2-BBF2-323EF7FB53A2 Q36877753-0637A29B-48E7-4FE2-8458-1E1F0718EA93 Q37328470-70415ABE-FC8A-4502-B7FB-D23FB06B4AFE Q37374203-DA6800E6-14F8-4344-ACC9-F387C705C74F Q37413462-9C9845A7-30F7-451C-821A-C1C84556B449 Q37559082-57790A6C-747B-471F-A1F2-B4BF84F5FF15 Q37700275-072F957F-7252-405A-B95A-2E8DADC1C627 Q38085616-EFE0E060-D2AE-4353-B928-B7658F3EF5B9 Q38125663-BA4A6CC6-170F-4668-A139-F2AE4FDD611A Q38232900-E85FA860-AC62-45F4-B967-3BF36F297672 Q38335335-B9D44B1D-BB66-417E-871D-ABA6384997C8 Q38428232-BBE3599E-A03B-4FF1-B5B3-59F1504815B7 Q38472574-2EF796B8-EE01-4B3A-A67B-C973D1F7ED71 Q38500010-E0DBEB95-0874-4E05-BDDF-6CA243C53D04 Q38789196-B6359C71-AA71-46AF-9556-61A60D76F3BE

P2860

Olfactory impairment in presymptomatic Alzheimer's disease.

http://www.wikidata.org/entity/Q33802937

description

2009 nî lūn-bûn

@nan

2009 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

Olfactory impairment in presymptomatic Alzheimer's disease.

@ast

Olfactory impairment in presymptomatic Alzheimer's disease.

@en

type

label

Olfactory impairment in presymptomatic Alzheimer's disease.

@ast

Olfactory impairment in presymptomatic Alzheimer's disease.

@en

prefLabel

Olfactory impairment in presymptomatic Alzheimer's disease.

@ast

Olfactory impairment in presymptomatic Alzheimer's disease.

@en

P1433

Q33802937-1A479183-8C07-4F1B-AE79-296373044A14

P1476

Q33802937-3AF66CD5-3736-471D-A895-6DB1FF4F3F24

P2093

Q33802937-215BD854-D35A-40AF-A746-4404DC63E55B

Q33802937-285EB673-212C-45C6-97CF-ADB772BBDCE9

Q33802937-51842166-6296-4AEE-8612-6D486461ACBE

Q33802937-95417DAE-5297-4C1D-97F5-6DD3DA9C0AFF

P2860

Q33802937-113BACCA-4C00-4BF6-817A-0F5419907106

Q33802937-140E181E-E362-4C37-8300-36E78BE2079A

Q33802937-1498556E-2E4B-402C-97E6-B227BEF6CDA2

Q33802937-14CB1005-4808-4CEC-A84F-05E0A7F9A1AC

Q33802937-1A36504A-9754-47E7-8BA2-FDD7C00CFAFC

Q33802937-1BB2EE82-F0B2-4DFD-BAEF-E8CEEF5B43E3

Q33802937-1BE4821F-C363-49CE-A966-39E2AEEA74D9

Q33802937-21D52057-9A99-449D-91B5-B9142FE2D8A9

Q33802937-2F64A64B-DA4E-48CC-B5C6-9106F8AD0A26

Q33802937-35942BA8-7C58-42B6-937C-CC8AB2264D3A

P304

Q33802937-09A37260-6EE1-4DB5-832F-66A942F85E3E

P31

Q33802937-80D556E3-B068-4270-90ED-8E33DB158B8F

P356

Q33802937-533D4A7D-F3CE-4FF1-83C1-882F6E2E9DD0

P407

Q33802937-42EB0C4C-1665-41C3-97B1-65B94CF2DC9D

P478

Q33802937-5E220019-C542-4085-8F41-04AF9907356A

P50

Q33802937-161CE841-AB32-41B6-9446-C1E443456783

Q33802937-1C3D85C8-D380-4778-AD1E-1F6F316020A3

P577

Q33802937-DF6E67ED-4E7C-4C43-B750-DD54866319ED

P5875

Q33802937-7FCEDBDB-8F90-4D4C-858D-29AA1C1CDB97

P698

Q33802937-57A78FAF-1147-4A29-8035-50655E8FCDE5

P921

Q33802937-F6874185-4264-4C5F-ADD5-DA306C73E211

P932

Q33802937-6A9FB145-03AC-4119-BD5B-D561C9C09371

P356

J.1749-6632.2009.04013.X

P1433

Annals of the New York Academy of Sciences

P1476

Olfactory impairment in presymptomatic Alzheimer's disease.

@en

P2093

Aron S Buchman

http://www.w3.org/2001/XMLSchema#string

Julie A Schneider

http://www.w3.org/2001/XMLSchema#string

Patricia A Boyle

http://www.w3.org/2001/XMLSchema#string

Robert S Wilson

http://www.w3.org/2001/XMLSchema#string

P2860

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

Random-effects models for longitudinal data

Assessment of lifetime participation in cognitively stimulating activities.

Natural history of mild cognitive impairment in older persons.

Alzheimer's disease: cell-specific pathology isolates the hippocampal formation.

The distribution of tangles, plaques and related immunohistochemical markers in healthy aging and Alzheimer's disease.

Relations between aging sensory/sensorimotor and cognitive functions.

Biological markers for therapeutic trials in Alzheimer's disease. Proceedings of the biological markers working group; NIA initiative on neuroimaging in Alzheimer's disease.

CSF markers for pathogenic processes in Alzheimer's disease: diagnostic implications and use in clinical neurochemistry.

The apolipoprotein E epsilon 2 allele and decline in episodic memory.

P304

730-735

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1749-6632.2009.04013.X

http://www.w3.org/2001/XMLSchema#string

P407

P478

1170

http://www.w3.org/2001/XMLSchema#string

P50

Steven E. Arnold

David A Bennett

P577

2009-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

26747329

http://www.w3.org/2001/XMLSchema#string

P698

19686220

http://www.w3.org/2001/XMLSchema#string

P921

Alzheimer's disease

P932

2857767

http://www.w3.org/2001/XMLSchema#string